2020
DOI: 10.1016/j.schres.2020.04.019
|View full text |Cite
|
Sign up to set email alerts
|

A review of negative symptom assessment strategies in youth at clinical high-risk for psychosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
32
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 51 publications
(32 citation statements)
references
References 72 publications
0
32
0
Order By: Relevance
“…Negative symptoms, defined as decreases in emotion, motivation, and/or expressive behavior [ 38 ], are a feature of schizophrenia and the attenuated psychosis syndrome [ 39 ]. Studies confirm that negative symptoms predict a number of poor clinical outcomes and limit social and vocational attainment [ 40 , 41 , 42 ]. Negative symptoms are highly associated with functional results in subjects that meet UHR criteria [ 43 ].…”
Section: Discussionmentioning
confidence: 99%
“…Negative symptoms, defined as decreases in emotion, motivation, and/or expressive behavior [ 38 ], are a feature of schizophrenia and the attenuated psychosis syndrome [ 39 ]. Studies confirm that negative symptoms predict a number of poor clinical outcomes and limit social and vocational attainment [ 40 , 41 , 42 ]. Negative symptoms are highly associated with functional results in subjects that meet UHR criteria [ 43 ].…”
Section: Discussionmentioning
confidence: 99%
“…It may still fail to adequately capture the subtleties of attenuated negative symptoms manifested in ARMS individuals. Development of a new rating instrument that specifically evaluates negative symptoms in young people with ARMS would facilitate comprehensive and more refined negative symptom assessment in at-risk populations (Strauss et al, 2020).…”
Section: Discussionmentioning
confidence: 99%
“…Alternatively, it should be noted that negative symptoms are most commonly evaluated in ARMS studies by either diagnostic instruments used to verify ARMS status (e.g., Structured Interview for Prodromal Symptoms (Miller et al, 2003) and Comprehensive Assessment of At-Risk Mental State (Yung et al, 2005)) or by other symptom scales (e.g., Positive and Negative Syndrome Scale (PANSS; Kay et al, 1987)), with its symptom items not well aligned with current conceptualizations of the five core domains of negative symptoms (anhedonia, avolition, asociality, blunted affect and alogia) recognized by the NIMH Consensus Development Conference on Negative Symptoms (Kirkpatrick et al, 2006;Marder & Galderisi, 2017). This may compromise the comprehensiveness of negative symptom measurement in prior studies (Strauss et al, 2020).…”
Section: Introductionmentioning
confidence: 99%
“…Advances continue to be made in understanding environmental and neurobiological determinants and mechanisms of transiting from prodromal to manifest psychotic states. Negative ( Devoe et al, 2021 ) and cognitive symptom evaluation through validated instruments aim to supplement the existing ones that are skewed towards identifying positive psychotic symptoms in prodromal states ( Strauss et al, 2020 ). Inflammatory ( Kelsven et al, 2020 ; Perry et al, 2021 ), neurolinguistic ( Bilgrami et al, 2022 ; Spencer et al, 2021 ), frontocentral P300 amplitudes, and biochemical assays (erythrocyte sphingomyelin and phosphatidylethanolamine) ( Alqarni et al, 2020a , Alqarni et al, 2020b ), have shown promise as biomarkers of transition ( Park and Miller, 2020 ; Tang et al, 2020 ).…”
Section: Prodrome Early Intervention Biomarkers and Early Psychosismentioning
confidence: 99%